Covid-19 Studies

The Potential Roles of Ficus carica Extract in the Management of COVID-19 Viral Infections: A Computer-Aided Drug Design Study.

Researchers sought alternative methods to traditional drug discovery due to its high costs, time constraints, and low success rates. This could lead to safer, more effective therapies while saving resources.

Hamed M et al (2023).
Curr Comput Aided Drug Des.
PubMed:
37594095

High efficient COVID-19 waste co-pyrolysis char/TiO(2) nanocomposite for photocatalytic reduction of Cr(VI) under visible light.

Researchers developed a photocatalyst made from COVID-19 masks and Moringa oleifera seed cake to reduce toxic metals in wastewater. It showed efficient reduction of Cr(VI) and high stability, offering a cost-effective solution for pollutant removal.

Nallaselvam T et al (2023).
Environ Sci Pollut Res Int.
PubMed:
37587400

Achyrocline satureioides as an adjuvant therapy for the management of mild viral respiratory infections in the context of COVID-19: Preliminary results of a randomized, placebo-controlled, and open-label clinical trial.

Achyrocline satureioides infusion reduced respiratory and neurological symptoms in viral respiratory infections, including COVID-19. It is a safe and effective treatment when combined with standard care.

Bastos CIM et al (2023).
Phytother Res.
PubMed:
37583121

Efficacy of Nanocurcumin as an Add-On Treatment for Patients Hospitalized with COVID-19: A Double-Blind, Randomized Clinical Trial.

Curcumin, derived from the rhizome, has multiple beneficial effects. It can be made into nanocurcumin for better properties like solubility, stability, and bioavailability.

Ahmadi S et al (2023).
Int J Clin Pract.
PubMed:
37547100

Inhibition by components of Glycyrrhiza uralensis of 3CLpro and HCoV-OC43 proliferation.

Compounds from (name of the source) showed inhibitory activity and binding affinity for the key enzyme 3CLpro in SARS-CoV-2, reducing viral growth and cytotoxicity in cells. This suggests they could be potential treatment options for COVID-19.

Kim JH et al (2023).
J Enzyme Inhib Med Chem.
PubMed:
37537881

Enhanced photocatalytic activity and antiviral evaluation of CuO@Fe2O3 NC for amoxicillin degradation and SARS-CoV-2 treatment.

Researchers developed copper oxide nanoparticles (CuO NPs) and CuO NPs decorated with hematite nanocomposites (CuO@Fe2O3 NC) using a green method. CuO@Fe2O3 NC exhibited enhanced photocatalytic and antiviral properties against SARS-CoV-2, making it valuable for disinfection and virus control.

Legmairi S et al (2023).
Nanotechnology.
PubMed:
37524077

Air mapping during COVID-19 and association between air pollutants and physiochemical parameters of the plants using structural equal modeling: a case study.

This study examined air pollution in Bhubaneswar during COVID-19 lockdown. Traffic restrictions improved air quality and certain plant species were found to be sensitive to pollution.

Das CP et al (2023).
Environ Monit Assess.
PubMed:
37493963

In silico identification of natural compounds against SARS-CoV-2 main protease from Chinese herbal medicines.

Researchers identified natural compounds from Chinese herbal medicines that can inhibit SARS-CoV-2 Mpro, providing potential treatments for COVID-19.

Kuang Y et al (2023).
Future Sci OA.
PubMed:
37485448